Company name: Ilera Therapeutics
Description: Developer of cannabis products and cannabinoids science focused on targeted medical indications. The company formulates products to conduct clinical trials and for the treatment of chemotherapy-induced nausea and vomiting.
Industry: Healthcare | Group: | Code:
Country: United States
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (no backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company is in talks to be acquired by Zelda Therapeutics for an undisclosed amount on October 9, 2019. The acquisition will enable the company to create a pipeline of clinically validated products under development and unique access to the world’s largest and fastest growing cannabis markets.
Number of active investors:
Profile last updated: 17-Oct-2019
Last known valuation:
Last known valuation date: